Clinical Trial Update: Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating an aminoglycoside-based antibiotic combination with protective isolation in critically ill neutropenic patients with sepsis; status and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Sepsis, Septic Shock | Phase 3 | Status: UNKNOWN